MedTrace Logo

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients

NCT01078584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7993

Last updated 2012-10-25

Study results available
· View outcomes & findings →

Summary

The in-MAU-tion study is conducted to determine the percentage of hypertensive participants with or without diabetes reaching CHEP (Canadian Hypertension Education Program) defined blood pressure targets. Additionally, the study assesses change in renal function (microalbuminuria, estimated glomerular filtration rate) in hypertensive participants treated with trandolapril (Mavik®) and examines patient satisfaction with trandolapril (Mavik®) therapy.

Conditions

Sponsors & Collaborators

  • McKesson Canada

    collaborator NETWORK

  • Abbott

    lead INDUSTRY

Principal Investigators

  • Linda Assouline, PhD · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01078584 on ClinicalTrials.gov